PSAR, Robert, Ondrej URBAN, Tomáš ROHAN, Michal STEPAN, Martin HILL a Marie CERNA. The role of abdominal ultrasonography in patients with isoattenuating pancreatic carcinoma. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2023, roč. 167, č. 4, s. 352-356. ISSN 1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2022.032.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The role of abdominal ultrasonography in patients with isoattenuating pancreatic carcinoma
Autoři PSAR, Robert (203 Česká republika), Ondrej URBAN (203 Česká republika), Tomáš ROHAN (203 Česká republika, garant, domácí), Michal STEPAN (203 Česká republika), Martin HILL (203 Česká republika) a Marie CERNA (203 Česká republika).
Vydání Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2023, 1213-8118.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30224 Radiology, nuclear medicine and medical imaging
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 0.900 v roce 2022
Kód RIV RIV/00216224:14110/23:00130239
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.5507/bp.2022.032
UT WoS 000828168100001
Klíčová slova anglicky pancreatic cancer; isoattenuating; ultrasound; ultrasonography; computed tomography; endoscopic ultrasonography
Štítky 14110216, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 26. 1. 2024 10:49.
Anotace
Aims. The main objective of this study was to determine the sensitivity of abdominal ultrasonography (US) in patients with isoattenuating pancreatic carcinoma and to compare the frequency of secondary signs on abdominal US and endoscopic ultrasonography (EUS) in these tumours. Methods. Twenty-four patients with histologically or cytologically verified isoattenuating pancreatic carcinoma who underwent abdominal US, contrast-enhanced CT and EUS of the pancreas as part of the diagnostic workup were included in this retrospective study. The sensitivity of abdominal US in detecting the isoattenuating pancreatic carcinoma was investigated and the frequency of secondary signs of isoattenuating pancreatic carcinoma on abdominal US and EUS was compared. Results. In 5 of 24 patients (21%) with isoattenuating pancreatic carcinoma, a hypoechogenic pancreatic lesion was directly visualised on abdominal US. Secondary signs were present on US in 21 patients (88%). These included dilatation of the common bile duct and/or intrahepatic bile ducts in 19/24 (79%), dilatation of the pancreatic duct in 3/24 (13%), abnormal contour/inhomogeneity of the pancreas in 1/24 (4%), and atrophy of the distal parenchyma in 1/24 (4%). Pancreatic duct dilatation was observed more frequently on EUS than on abdominal US (P=0.002). For other secondary signs, there was no significant difference in their detection on abdominal US and EUS (P=0.61-1.00). Conclusion. Abdominal US is capable of detecting secondary signs of isoattenuating pancreatic carcinoma with high sensitivity and has the potential to directly visualise these tumours.
VytisknoutZobrazeno: 24. 6. 2024 05:13